한글목차

바이오의약품 첨가제 동향 및 전망

세계 바이오의약품 첨가제 시장은 2024년부터 2030년까지 5.6%의 연평균 복합 성장률(CAGR)을 나타내고, 2030년까지 약 40억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 다기능 첨가제의 채택이 증가하고 제약 회사가 제네릭 시장에 집중하고 있다는 점입니다. 세계 바이오의약품 첨가제 시장의 미래는 가용화 및 계면활성제/유화제, 폴리올, 탄수화물 시장에서 기회가 있을 것으로 예상됩니다.

바이오의약품 첨가제 시장 인사이트

Lucintel은 단백질 치료제에 대한 수요 증가로 인해 탄수화물이 예측 기간 동안 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

북미는 바이오 의약품 제조에 대한 수요가 높기 때문에 예측 기간 동안 가장 규모가 큰 지역으로 남을 것입니다.

자주 묻는 질문

Q1. 시장 규모는?

A1. 세계 바이오 의약품 첨가제 시장은 2030년까지 약 40억 달러에 달할 것으로 예상됩니다.

Q2. 시장 성장 전망은?

A2. 세계 바이오의약품 첨가제 시장은 2024년부터 2030년까지 연평균 5.6%의 성장률을 보일 것으로 예상됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 무엇인가?

A3.이 시장의 주요 촉진요인은 다기능 첨가제 채택이 증가하고 제약 회사가 제네릭 시장에 집중하고 있다는 것입니다.

Q4. 시장의 주요 부문은?

A4. 바이오 의약품 첨가제 시장의 미래는 가용화/계면활성제/유화제, 폴리올, 탄수화물 시장에서 기회가 있고 유망합니다.

Q5. 시장의 주요 기업은?

A5. 바이오 의약품 첨가제 주요 기업은 다음과 같습니다.

• Merck
• Colorcon
• BASF
• Associated British Foods
• Signet Excipients
• Sigachi Industries
• Spectrum Chemical Manufacturing
• Roquette Freres
• IMCD
• Clariant

Q6. 향후 가장 큰 시장 부문은?

A6.Lucintel은 단백질 치료제에 대한 수요 증가로 인해 탄수화물이 예측 기간 동안 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

Q7. 향후 5년간 가장 큰 시장으로 성장할 것으로 예상되는 지역은?

A7. 북미는 바이오 의약품 제조에 대한 수요가 높기 때문에 예측 기간 동안 가장 규모가 큰 지역으로 남을 것입니다.

Q8. 보고서 커스터마이징이 가능한가?

A8. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 바이오의약품 첨가제 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 바이오의약품 첨가제 시장 동향(2018-2023) 및 예측(2024-2030)
• 제품별 세계의 바이오의약품 첨가제 시장
  • 용해제 및 계면활성제/유화제
  • 폴리올
  • 탄수화물

제4장 지역별 시장 동향과 예측 분석(2018-2030년)

• 지역별 세계의 바이오의약품 첨가제 시장
• 북미의 바이오의약품 첨가제 시장
• 유럽의 바이오의약품 첨가제 시장
• 아시아태평양의 바이오의약품 첨가제 시장
• 기타 지역의 바이오의약품 첨가제 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품별 세계의 바이오의약품 첨가제 시장 성장 기회
  • 지역별 세계의 바이오의약품 첨가제 시장 성장 기회
• 세계의 바이오의약품 첨가제 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 바이오의약품 첨가제 시장 능력 확대
  • 세계 바이오의약품 첨가제 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증과 라이선싱

제7장 유력 기업 개요

• Merck
• Colorcon
• BASF
• Associated British Foods
• Signet Excipients
• Sigachi Industries
• Spectrum Chemical Manufacturing
• Roquette Freres
• IMCD
• Clariant

영문목차

Biopharmaceuticals Exicipents Trends and Forecast

The future of the global biopharmaceuticals exicipents market looks promising with opportunities in the solubilizes & surfactants/emulsifiers, polyols, and carbohydrates markets. The global biopharmaceuticals exicipents market is expected to reach an estimated $4 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are increasing adoption of multifunctional excipients and growing focus of pharmaceutical players on the generic market.

A more than 150-page report is developed to help in your business decisions.

Biopharmaceuticals Exicipents by Segment

The study includes a forecast for the global biopharmaceuticals exicipents by products and region.

Biopharmaceuticals Exicipents Market by Products [Shipment Analysis by Value from 2018 to 2030]:

• Solubilizes & Surfactants/Emulsifiers
• Polyols
• Carbohydrates

Biopharmaceuticals Exicipents Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Biopharmaceuticals Exicipents Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biopharmaceuticals exicipents companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopharmaceuticals exicipents companies profiled in this report include-

• Merck
• Colorcon
• BASF
• Associated British Foods
• Signet Excipients
• Sigachi Industries
• Spectrum Chemical Manufacturing
• Roquette Freres
• IMCD
• Clariant

Biopharmaceuticals Exicipents Market Insights

Lucintel forecasts that carbohydrates will remain the largest segment over the forecast period due to increasing demand for protein therapeutics.

North America will remain the largest region over the forecast period due to substantial need for biopharmaceutical production.

Features of the Global Biopharmaceuticals Exicipents Market

Market Size Estimates: Biopharmaceuticals exicipents market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biopharmaceuticals exicipents market size by products, region, and region in terms of value ($B).

Regional Analysis: Biopharmaceuticals exicipents market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products and regions for the biopharmaceuticals exicipents market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopharmaceuticals exicipents market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the biopharmaceuticals exicipents market size?

Answer: The global biopharmaceuticals exicipents market is expected to reach an estimated $4 billion by 2030.

Q2. What is the growth forecast for biopharmaceuticals exicipents market?

Answer: The global biopharmaceuticals exicipents market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the biopharmaceuticals exicipents market?

Answer: The major drivers for this market are increasing adoption of multifunctional excipients and growing focus of pharmaceutical players on the generic market.

Q4. What are the major segments for biopharmaceuticals exicipents market?

Answer: The future of the biopharmaceuticals exicipents market looks promising with opportunities in the solubilizes & surfactants/emulsifiers, polyols, and carbohydrates markets.

Q5. Who are the key biopharmaceuticals exicipents market companies?

Answer: Some of the key biopharmaceuticals exicipents companies are as follows.

• Merck
• Colorcon
• BASF
• Associated British Foods
• Signet Excipients
• Sigachi Industries
• Spectrum Chemical Manufacturing
• Roquette Freres
• IMCD
• Clariant

Q6. Which biopharmaceuticals exicipents market segment will be the largest in future?

Answer: Lucintel forecasts that carbohydrates will remain the largest segment over the forecast period due to increasing demand for protein therapeutics.

Q7. In biopharmaceuticals exicipents market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to substantial need for biopharmaceutical production.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biopharmaceuticals exicipents market by products (solubilizes & surfactants/emulsifiers, polyols, and carbohydrates) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biopharmaceuticals Exicipents Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Biopharmaceuticals Exicipents Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Biopharmaceuticals Exicipents Market by Products
  • 3.3.1: Solubilizes & Surfactants/Emulsifiers
  • 3.3.2: Polyols
  • 3.3.3: Carbohydrates

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Biopharmaceuticals Exicipents Market by Region
• 4.2: North American Biopharmaceuticals Exicipents Market
• 4.3: European Biopharmaceuticals Exicipents Market
  • 4.3.1: European Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates
• 4.4: APAC Biopharmaceuticals Exicipents Market
  • 4.4.1: APAC Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates
• 4.5: ROW Biopharmaceuticals Exicipents Market
  • 4.5.1: ROW Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biopharmaceuticals Exicipents Market by Products
  • 6.1.2: Growth Opportunities for the Global Biopharmaceuticals Exicipents Market by Region
• 6.2: Emerging Trends in the Global Biopharmaceuticals Exicipents Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biopharmaceuticals Exicipents Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceuticals Exicipents Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Merck
• 7.2: Colorcon
• 7.3: BASF
• 7.4: Associated British Foods
• 7.5: Signet Excipients
• 7.6: Sigachi Industries
• 7.7: Spectrum Chemical Manufacturing
• 7.8: Roquette Freres
• 7.9: IMCD
• 7.10: Clariant